Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sands, BE
  • Moss, AC
  • Armuzzi, A
  • Marshall, John Kenneth
  • Lindsay, JO
  • Sandborn, WJ
  • Danese, S
  • Tsilkos, K
  • Lawendy, N
  • Zhang, H
  • Friedman, GS
  • Chan, G
  • Krichbaum, DW
  • Su, C

publication date

  • February 1, 2018